+ Follow DR. ADELAIDA IBOLEON-DY Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 228628
[Title] => Landmark study presented in US gab
[Summary] => More than 25,000 heart specialists and researchers gathered at the Orange County Convention Center in Orlando, Florida recently for the 76th annual scientific sessions of the American Heart Association (AHA) to discuss new developments in the management of cardiovascular diseases.
Researchers said a new clinical study provides evidence that treatment of heart attack patients with the angiotensin receptor blocker valsartan is as effective as the proven dose of the angiotensin-converting enzyme (ACE) inhibitor captopril.
[DatePublished] => 2003-11-20 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
DR. ADELAIDA IBOLEON-DY
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 228628
[Title] => Landmark study presented in US gab
[Summary] => More than 25,000 heart specialists and researchers gathered at the Orange County Convention Center in Orlando, Florida recently for the 76th annual scientific sessions of the American Heart Association (AHA) to discuss new developments in the management of cardiovascular diseases.
Researchers said a new clinical study provides evidence that treatment of heart attack patients with the angiotensin receptor blocker valsartan is as effective as the proven dose of the angiotensin-converting enzyme (ACE) inhibitor captopril.
[DatePublished] => 2003-11-20 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
November 20, 2003 - 12:00am